13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001696802
Total reported value
$92.0M
$92.0M
45 檔
57.5%
As reported in its official Q1 2025 Form 13F filing, Forefront Analytics, LLC's tracked investment portfolio stood at $92.0M with 45 total positions.
In Q1 2025, Forefront Analytics, LLC displayed an active expansion posture, initiating 45 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NULV | Nuveen Esg Large-cap Val ETF | ETF-Other | 25.85% | -0.45% | -13.12% | |
| 2 | SPYX | Ss Spdr S&p 500 Foss Fl ETF | ETF-Large Cap & Growth | 10.73% | — | +64.10% | |
| 3 | MTUM | Ishares Msci USA Momentum Fa | ETF-Other | 9.71% | +3.81% | +7.26% | |
| 4 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 8.17% | +2.84% | +5.71% | |
| 5 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 6.39% | +0.92% | +0.46% | |
| 6 | HDV | Ishares Core High Dividend E | ETF-Other | 6.01% | +1.81% | +25.18% | |
| 7 | DBEF | Xtrackers Msci Eafe Hedged E | ETF-Other | 5.34% | +1.82% | +8.64% | |
| 8 | USMV | Ishares Msci USA Min Vol Fac | ETF-Other | 4.88% | — | -0.13% | |
| 9 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 2.96% | +0.96% | -0.65% | |
| 10 | VTV | Vanguard Value ETF | ETF-Other | 2.85% | +0.02% | +8.97% | |
| 11 | HEEM | Ishares Crncy Hedgd Msci Em | ETF-Other | 2.07% | +0.86% | +1.88% | |
| 12 | NVDA | Nvidia CORP | Stock-Tech | 1.87% | +1.99% | +0.17% | |
| 13 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 1.76% | — | +0.33% | |
| 14 | EES | Wisdomtree US Smallcap Fund | ETF-Other | 1.46% | +0.09% | +1.33% | |
| 15 | VB | Vanguard Small-cap ETF | ETF-Other | 1.09% | — | +0.40% | |
| 16 | JPM | Jpmorgan Chase & Co | Stock-Financials | 0.95% | +0.45% | +0.45% | |
| 17 | DE | Deere & Co | Stock-Industrials | 0.61% | +0.23% | +0.36% | |
| 18 | EMLP | First Trust North American E | ETF-Other | 0.57% | — | -93.85% | |
| 19 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.49% | +0.15% | +4.19% | |
| 20 | LTPZ | Pimco 15+ Yr US Tips Indx | ETF-Other | 0.47% | — | -95.77% | |
| 21 | INDA | Ishares Msci India ETF | ETF-Other | 0.44% | — | — | |
| 22 | IGF | Ishares Global Infrastructur | ETF-Other | 0.43% | — | -91.46% | |
| 23 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.41% | +0.13% | +54.09% | |
| 24 | SSO | Proshares Ultra S&p500 | ETF-Other | 0.38% | +0.21% | — | |
| 25 | TIP | Ishares Tips Bond ETF | ETF-Other | 0.38% | — | -94.81% | |
| 26 | MDT | Medtronic plc | Stock-Healthcare | 0.31% | +0.03% | -2.47% | |
| 27 | UWM | Proshares Ultra Russell2000 | ETF-Other | 0.30% | +0.24% | — | |
| 28 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.30% | +0.10% | +26.88% | |
| 29 | PM | Philip Morris International | Stock-Consumer Staples | 0.26% | +0.07% | — | |
| 30 | IEI | Ishares 3-7 Year Treasury Bo | ETF-Gov Bonds | 0.25% | — | -92.20% | |
| 31 | PFE | Pfizer Inc | Stock-Healthcare | 0.25% | +0.15% | -41.95% | |
| 32 | LEGN | Legend Biotech Corp-adr | Stock-Other | 0.25% | +0.07% | — | |
| 33 | DJP | Ipath Bloomberg Commodity In | ETF-Commodities | 0.25% | — | -97.27% | |
| 34 | IEF | Ishares 7-10 Year Treasury B | ETF-Gov Bonds | 0.24% | — | -88.50% | |
| 35 | INCY | Incyte CORP | Stock-Healthcare | 0.23% | +0.27% | -30.47% | |
| 36 | BKLN | Invesco Senior Loan ETF | ETF-Other | 0.23% | — | -96.79% | |
| 37 | ✓ | Zura Bio LTD | Stock-Other | 0.16% | +0.09% | +101.56% | |
| 38 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.12% | -0.04% | EXIT | |
| 39 | GERN | Geron CORP | Stock-Other | 0.11% | +0.05% | +231.04% | |
| 40 | COGT | Cogent Biosciences Inc | Stock-Other | 0.10% | — | +1.85% | |
| 41 | ✓ | Immatics NV | Stock-Other | 0.08% | — | +0.38% | |
| 42 | 2662247D | Iteos Therapeutics Inc | Stock-Other | 0.08% | — | — | |
| 43 | CTMX | Cytomx Therapeutics Inc | Stock-Other | 0.07% | +0.05% | +55.73% | |
| 44 | ANNX | Annexon Inc | Stock-Other | 0.06% | +0.02% | +73.99% | |
| 45 | NKTX | Nkarta Inc | Stock-Other | 0.06% | +0.01% | -2.85% |
According to official SEC Form 13F filings, Forefront Analytics, LLC reported a total U.S. public equity portfolio value of $92.0M across 45 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NULV, SPYX, MTUM) accounted for 57.5% of total reported equity market value during Q1 2025.
Top New Position Initiated
NULV
市值: $22.5M
During Q1 2025, Forefront Analytics, LLC's top holdings by market value included NULV (25.9%)、SPYX (10.7%)、MTUM (9.7%). The largest single position, NULV, represented 25.9% of total portfolio value.
In Q1 2025, Forefront Analytics, LLC made 45 total portfolio adjustments, initiating 45 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.